Skip to main content
Premium Trial:

Request an Annual Quote

Marine Biological Laboratory Dives into Squid Genome Project

NEW YORK, Oct. 24 (GenomeWeb News) - The Marine Biological Laboratory of Woods Hole, Mass., said today that it has launched the Squid Genome Project -- an international effort to sequence and characterize the genome of the calamari squid.

 

The long-finned squid has a nerve cell fiber, called a giant axon, which is 1,000 times wider than the average human axon. This makes the organism ideal for studying neurological diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's, Huntington's, and Alzheimer's disease, the MBL said.

 

The effort is co-directed Joe DeGiorgis of MBL and Peter Burbach, of the Rudolf Magnus Institute of Neuroscience at the University Medical Center Utrecht. Support for the project comes from the Laboratory of Neurobiology at the National Institutes of Health and the Netherlands Brain Foundation. Around 41 reserchers worldwide are expected to have some involvement in the project.

 

So far, DeGiorgis and his colleagues have identified more than 3,000 out of what they predict will total approximately 35,000 genes in the squid genome.

 

"It's a good beginning, but it's the tip of the iceberg, and completing the project is money dependent," DeGiorgis said in a statement.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.